Shenzhen Salubris Pharmaceuticals Co., Ltd.
AG·尊龙凯时
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
News & Trends
05
2023-02
The clinical progress of SAL0119 tablets for the treatment of ankylosing spondylitis and rheumatoid arthritis
18
2023-01
Progress of S086 for the treatment of mild to moderate primary hypertension
11
2023-01
Clinical trial approved! Good news for SAL0133 tablets
11
2023-01
SAL008 injection for the treatment of advanced solid tumors approved for clinical trial
11
2023-01
The application for a clinical trial of SAL0133 tablets for the treatment of mild/common COVID-19 in adults was accepted
11
2023-01
New clinical progress of SAL003 for the treatment of hypercholesterolemia and mixed hyperlipidemia
目前在第
2
页,
共有
9
页,
共有
51
条记录
第一页
上一页
1
2
3
4
5
下一页
最后一页
跳转到
页